Original Research
Published on 01 May 2023
HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors
in Clinical and Diagnostic Microbiology and Immunology
- 3,505 views
- 10 citations